AVH 2.91% $3.00 avita medical inc.

Ann: Q1 2023 Investor Presentation, page-19

  1. 351 Posts.
    lightbulb Created with Sketch. 298
    Todays call was very good. Should listen to the recording. FDA approval dates: June 7th soft tissue June 17th Vitiligo, Jan 1 2024 Recell go. International expansion 24 countries planned with Recell Go to make adoption much simpler next to no training apparently a non medical person can learn to use it within 1 minute

    as always the writing appears to be firmly written on the wall….
 
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.